Ziel Biosciences
PrivateLast Round
Early Funding
Sep 27, 2022
Total Funding Raised
$33.15M
Company Overview
Ziel Biosciences operates in Healthcare & Life Sciences and is based in Porto Alegre. Its latest recorded funding round was an Early Funding round in September 2022.
Ziel Biosciences is a biotechnology company that develops oncology technology-based products for cancer treatment and women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ziel Biosciences Comparables
Compare Ziel Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Teal Health | 77% | |
| Gynius Plus AB | 75% | |
| Eve Medical | 70% |
For institutional investors. Book with your work email.
Ziel Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 27, 2022 | ||||
| Series A | Sep 26, 2019 | ||||
| Grant | Jun 3, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ziel Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mass General Brigham Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2022
$7.5M raised in early funding.
- Jun 3, 2013
$50K grant received from Commonwealth Research Commercialization Fund.
For institutional investors. Book with your work email.
Ziel Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ziel Biosciences's valuation, stock price, and market status.
Is Ziel Biosciences a public or private company?
Ziel Biosciences is a private company.
What is the current stock price of Ziel Biosciences?
Ziel Biosciences is a private company, so its shares have no public market price. Caplight tracks Ziel Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ziel Biosciences worth (valuation)?
Valuation information for Ziel Biosciences is not publicly available.
Can I buy Ziel Biosciences stock?
Ziel Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ziel Biosciences's last funding round?
Ziel Biosciences's most recent funding round was Early Funding on September 27, 2022.
Who are the main investors in Ziel Biosciences?
Key investors in Ziel Biosciences include Mass General Brigham Innovation.
Will Ziel Biosciences IPO soon?
No public IPO plans have been announced for Ziel Biosciences.
How can I track Ziel Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Ziel Biosciences's shares on secondary markets.